viewTHC Global Group Ltd

The Hydroponics Company to outline ‘farm to pharma’ cannabis strategy at CEO Session

The company has a vertically integrated model incorporating a growing site, an R&D facility and a manufacturing facility.

Cannabis plants
Andrew Beehag will present at the Proactive CEO Session in Sydney next Monday

The Hydroponics Company Ltd’s (ASX:THC) vertically integrated ‘farm to pharma’ medicinal cannabis strategy will be outlined during the Proactive CEO Session in Sydney on Monday, October 22.

The company’s Medicinal Cannabis Division lead Andrew Beehag will make the presentation to investors.

He will also explain the reasons for the company’s intended name change to THC Global Group Limited.

READ: The Hydroponics Company to change name to THC Global Group Limited

This will be one of 14 resolutions put to shareholders to vote on at the company’s annual general meeting on November 15, 2018.

THC’s strategy begins with a growing site in northern New South Wales and a growing, research and development facility in Queensland.

It flows through to an industry-leading biopharmaceutical manufacturing facility ready for pharma-grade production.

THC also has established international commercial partnerships with global industry leaders across Europe, Middle East, North America and Australia.

READ: The Hydroponics Company imported medicinal cannabis products available to Australian patients

Beehag will also outline the company’s near-term plans to complete licensing and permitting activities on existing facilities and expand its product distribution.

He has been associated with the company from its inception in 2016, including its successful licensing and partnership alliancing with Endoca and BOL Pharma.

As a key part of the team, he has helped build THC’s successful investment and partnership strategy, gearing up THC to supply to domestic patients and the export market.

Register for the CEO Session today to find out more.

Sydney details, Monday, October 22, 2018

Also featuring will be MMJ PhytoTech Ltd (ASX:MMJ), Yandal Resources Limited (ASX:YRL), High Peak Royalties Ltd (ASX:HPR) and Minotaur Exploration Ltd (ASX:MEP).

Quick facts: THC Global Group Ltd

Price: 0.3 AUD

Market: ASX
Market Cap: $50.41 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...



Full interview: THC Global Group granted GMP Licence for Southport cannabis...

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris updates Proactive on being granted a licence to manufacture therapeutic goods for the company’s Southport Facility, known as a GMP Licence, by the Australian Therapeutic Goods Administration (TGA). This milestone...

on 29/1/20

2 min read